• $675,854.00
    Market Cap
  • -59.56%
    1-Year Change
  • Diagnostics & Research
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
310,789
+10,259.63%
3,000
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
11,000
N/A
N/A
N/A
Gross Profit
0
N/A
0
-100.00%
187,422
+6,147.40%
3,000
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
N/A
N/A
N/A
N/A
-1.1M
-74.06%
-4.4M
N/A
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
14,000
-22.22%
18,000
N/A
Total Operating Expenses
238,755
-74.60%
939,922
-73.43%
3.5M
+714.35%
434,434
N/A
Operating Profit
-238,755
-74.27%
-927,922
-73.68%
-3.5M
+734.64%
-422,434
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
-36,000
+19.67%
-30,082
-69.62%
-99,023
+798.74%
-11,018
N/A
Interest Income and Expense and Net
-36,000
+19.67%
-30,082
-69.62%
-99,023
+798.74%
-11,018
N/A
Total Nonoperating Income and Expense
2.6M
+221.85%
-2.1M
+497.20%
-359,023
-12,067.43%
3,000
N/A
Income before Taxes
2.4M
+177.27%
-3.1M
-20.92%
-3.9M
+796.25%
-433,452
N/A
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
1.6M
N/A
N/A
N/A
N/A
N/A
Net Income
2.4M
N/A
N/A
N/A
-4.2M
+446.84%
-765,730
N/A
Net Income from Continuing Operations Applicable to Common
2.4M
+177.27%
-3.1M
-20.92%
-3.9M
+796.25%
-433,452
N/A
Basic EPS and Net Income
0.05
+171.43%
-0.07
-22.22%
-0.09
+350.00%
-0.02
N/A
Diluted EPS and Net Income
0.05
+171.43%
-0.07
-22.22%
-0.09
+350.00%
-0.02
N/A
Basic Weighted Average Shares
46.9M
0.00%
46.9M
0.00%
46.9M
0.00%
46.9M
N/A
Diluted Weighted Average Shares
47.8M
+1.95%
46.9M
0.00%
46.9M
0.00%
46.9M
N/A
Balance Sheet
Cash and Cash Equivalents
333
-94.54%
6,099
-99.06%
648,000
+10,111.16%
6,346
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
333
-94.54%
6,099
-99.06%
648,000
+10,111.16%
6,346
N/A
Total Current Assets
15,786
-50.47%
31,871
-63.20%
86,603
+47.02%
58,907
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
53,000
+35.90%
39,000
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
9,000
-60.87%
23,000
N/A
Total Long-Term Assets
N/A
N/A
2,000
-77.78%
9,000
-60.87%
23,000
N/A
Total Assets
15,786
-90.14%
160,111
-92.90%
2.3M
-1.38%
2.3M
N/A
Income Taxes Payable
30,903
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
608,405
+69.64%
358,646
+43.46%
250,000
N/A
N/A
N/A
Total Current Liabilities
571,365
-89.23%
5.3M
+1,430.96%
346,480
+434.06%
64,876
N/A
Total Long-Term Debt
900,000
-48.87%
1.8M
-47.06%
3.3M
+711.97%
409,450
N/A
Total Long-Term Liabilities
750,000
0.00%
750,000
-80.57%
3.9M
+1,238.05%
288,450
N/A
Total Liabilities
2.2M
-59.33%
5.3M
+26.11%
4.2M
+1,090.42%
353,326
N/A
Retained Earnings
-294.0M
-0.80%
-296.4M
+1.10%
-293.1M
+1.45%
-288.9M
N/A
Total Stockholders Equity
-2.1M
-58.37%
-5.1M
+163.61%
-2.0M
-200.97%
1.9M
N/A
Total Shares Outstanding
46.9M
0.00%
46.9M
0.00%
46.9M
0.00%
46.9M
N/A
Cash Flow
Cash from Operating Activities
-167,633
-38.36%
-271,964
-21.91%
-348,283
+91.03%
-182,320
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
N/A
N/A
-250,000
0.00%
-250,000
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
161,867
-65.92%
475,000
-26.36%
645,000
+258.33%
180,000
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
96.46%
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
-1,134.47%
N/A
N/A
N/A
Return on Assets
2,717.56%
N/A
N/A
N/A
-184.43%
N/A
N/A
N/A
Return on Equity
-65.61%
N/A
N/A
N/A
44,892.00%
N/A
N/A
N/A
Revenue Growth
N/A
N/A
N/A
N/A
10,259.63%
N/A
N/A
N/A
Current Ratio
0.03
+360.00%
0.006
-97.60%
0.25
N/A
N/A
N/A
Cash Ratio
0.0006
-45.45%
0.001
-99.94%
1.87
N/A
N/A
N/A
Debt-to-Equity Ratio
-0.70
+70.99%
-0.41
-77.51%
-1.83
N/A
N/A
N/A
Debt-to-Assets Ratio
95.55
+622.07%
13.23
+734.65%
1.59
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow